Walmart Enhances Walmart+ To Compete With Amazon Prime: Key Differences Unveiled
Walmart+ Week offers perks like free shipping, fuel savings, and a Paramount+ subscription at a lower cost than Amazon Prime, in competition with Amazon.
Teva Engages In Settlement Talks Over Medicare Kickback Allegations
Teva Pharmaceutical is negotiating with the DOJ to settle a lawsuit alleging it paid kickbacks through charities to boost Copaxone sales, risking up to $10 billion in damages.
Microsoft, Apple Step Aside: Nvidia Is Now The Most Valuable Public Company In The World
NVIDIA Corp (NASDAQ:NVDA) stock has been a runaway freight train since the start of the year, outpacing a large majority of the market.
Virgin Orbit Fake Offer: SEC Sues Texas Man For $20M Bid
The SEC has sued Matthew Brown for an alleged $200 million fraudulent offer to rescue Virgin Orbit, accusing him of fabricating credentials and a bank statement. Virgin Orbit terminated discussions due to credibility issues.
Analyst Projects Strong Growth for GSK-Innoviva Partnered Respiratory Drugs
Discover Cantor Fitzgerald's analysis on Innoviva, highlighting its unique royalty-based business model with GSK for asthma and COPD products.
Instacart Inks Nationwide Pact With Sally Beauty – What’s Going On?
Maplebear (Instacart) partners with Sally Beauty for nationwide same-day delivery, enhancing access to beauty products amid contrasting stock performances.
Best Buy Launches Major AI PC Training For Microsoft Copilot+ Release: Report
Best Buy is set to launch Microsoft Corp.'s AI-powered Copilot+ PCs, initiating its most extensive employee training program in a decade, covering sales to support for over 30,000 employees.
Ford Plans Further Job Reductions in Germany, Spain, And UK: Report
Ford Motor is reportedly set to reduce its workforce further in Germany, Spain, and the U.K. as it adapts to the new demands of electric vehicle production, with detailed plans expected by the end of June.
What’s Going On With Small-Cap Cancer Focused XBiotech On Tuesday?
XBiotech reveals results from its Phase 1/Phase 2 1-BETTER Study for advanced pancreatic cancer, highlighting the safety and tolerability of Natrunix with the ONIVYDE + 5-Fluorouracil + Leucovorin regimen.
What’s Going On With Dollar Tree Shares Today?
Dollar Tree faces FDA warning letter and share decline amid ongoing issues with adulterated products and strategic considerations for its Family Dollar chain.